Author

Maurice P.H.M. Jansen

Erasmus MC Cancer InstituteORCID 0000-0003-1258-9804Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:DNA methylation· 1 Approach:machine learning (classical)· 1 Assay:spatial transcriptomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A.-M. Baker· 1 shared Andrea SottorivaiD· 1 shared Ann‐Marie BakeriD· 1 shared Anouk C. de JongiD· 1 shared Chris J. de WitteiD· 1 shared Christina Stangl· 1 shared Christopher KimberleyiD· 1 shared Claire LynniD· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A.-M. Baker

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyNature GeneticsPeer-reviewedJun 1, 2024

Epigenome and early selection determine the tumour-immune evolutionary trajectory of colorectal cancer

Eszter Lakatos, Vinaya Gunasri, Luis Zapata…·Trevor A. Graham

This study shows that immune evasion in colorectal cancer follows a 'Big Bang' pattern, where early genetic and epigenetic changes drive subsequent tumor-immune evolution.

27 citationstop 4%

humanbulk RNA-seq

𝕏 PostBluesky

Genetic & Genomic MedicineGenome MedicinePeer-reviewedMay 18, 2021

Rapid identification of genomic structural variations with nanopore sequencing enables blood-based cancer monitoring

Jose Espejo Valle-Inclán, Christina Stangl, Anouk C. de Jong…·Wigard P. Kloosterman

SHARC rapidly identifies somatic genomic structural variations from nanopore sequencing for blood-based cancer monitoring, detecting ten SVs per sample and enabling treatment response tracking in metastatic prostate cancer.

46 citationstop 4%

humanwhole-genome sequencing

𝕏 PostBluesky